Toggle Main Menu Toggle Search

ePrints

Nijmegen paediatric CDG rating scale: a novel tool to assess disease progression

Lookup NU author(s): Professor Bobby McFarland, Dr Joanna Elson

Downloads


Abstract

Congenital disorders of glycosylation (CDG) are a group of clinically heterogeneous inborn errors of metabolism. At present, treatment is available for only one CDG, but potential treatments for the other CDG are on the horizon. It will be vitally important in clinical trials of such agents to have a clear understanding of both the natural history of CDG and the corresponding burden of disability suffered by patients. To date, no multicentre studies have attempted to document the natural history of CDG. This is in part due to the lack of a reliable assessment tool to score CDG's diverse clinical spectrum. Based on our earlier experience evaluating disease progression in disorders of oxidative phosphorylation, we developed a practical and semi-quantitative rating scale for children with CDG. The Nijmegen Paediatric CDG Rating Scale (NPCRS) has been validated in 12 children, offering a tool to objectively monitor disease progression. We undertook a successful trial of the NPCRS with a collaboration of nine experienced physicians, using video records of physical and neurological examination of patients. The use of NPCRS can facilitate both longitudinal and natural history studies that will be essential for future interventions.


Publication metadata

Author(s): Achouitar S, Mohamed M, Gardeitchik T, Wortmann SB, Sykut-Cegielska J, Ensenauer R, de Baulny HO, Ounap K, Martinelli D, de Vries M, McFarland R, Kouwenberg D, Theodore M, Wijburg F, Grunewald S, Jaeken J, Wevers RA, Nijtmans L, Elson J, Morava E

Publication type: Article

Publication status: Published

Journal: Journal of Inherited Metabolic Disease

Year: 2011

Volume: 34

Issue: 4

Pages: 923-927

Print publication date: 03/05/2011

ISSN (print): 0141-8955

ISSN (electronic): 1573-2665

Publisher: Springer

URL: http://dx.doi.org/10.1007/s10545-011-9325-5

DOI: 10.1007/s10545-011-9325-5


Altmetrics

Altmetrics provided by Altmetric


Actions

    Link to this publication


Share